Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 33, 1999 - Issue 2
Submit an article Journal homepage
6
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Predictive Value of Prostate-specific Antigen, Tumour Stage and Tumour Grade for the Outcome of Bone Scintigraphy in Patients with Newly Diagnosed Prostate Cancer

Anders Rydh, Radisa Tomic, Björn Tavelin, Sven-Ola Hietala, Jan-Erik Damber From the Departments of Diagnostic Radiology, Urology and Oncology, University Hospital of Northern Sweden, Umea, Sweden
Pages 89-93 | Published online: 09 Jul 2009

REFERENCES

  • Oesterling JE. Using prostate-specific antigen to elim-inate unnecessary diagnostic tests: significant world-wide economic implications. Urology 1995; 46 Suppl A: 26–33.
  • Chybowski FM, Larson Keller JJ, Bergstrahl EJ, Oesterling JE. Predicting bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1991; 145: 313–8.
  • Rudoni M, Antonini G, Favro M, Baroli A, Brambilla M, Cardani G, et al. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer. Eur J Nucl Med 1995; 22: 207–11.
  • Sassine AM, Schulman C. Clinical use of prostate-specific antigen in the staging of patients with prostatic carcinoma. Eur Urol 1993; 23: 348–51.
  • Grundtman S, Borghede G, Hedelin H. Association between serum-PSA and bone metastasis in prostatic cancer. Scand J Urol Nephrol 1996; 30 Suppl 181: 17–8.
  • Grundtman S, Borghede G, Hedelin H. Serum-PSA 10 does not exclude bone metastasis in prostatic cancer. Scand J Urol Nephrol 1996; 30 Suppl 181: 18.
  • Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update. J Urol 1994; 152: 1358–68.
  • Hermanek P. Sobin LH TNM classification of malignant tumours, 2nd rev. ed. Berlin: Springer Verlag, 1992.
  • Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Mohammed M. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988; 61: 195–202.
  • Cleary PD, Bush BT, Kessler LG. Evaluating the use of mental health screening scales in primary care settings using receiver operating characteristic curves. Med Care 1987; 25: 90–8.
  • Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57–60.
  • Kemp PM, Maguire GA, Bird NJ. Which patients with prostatic carcinoma require a staging bone scan? Br J Urol 1997; 79: 611–4.
  • Haukaas S, Roervik J, Halvorsen OJ, Foellings M. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br J Urol 1997; 79: 770–6.
  • Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 1996; 47: 708–12.
  • Lee CT, Oesterling JE. Using prostate-specific antigen to eliminate the staging bone scan. Urol Clin North Am 1997; 24: 389–94.
  • Chengazi VU, Fenely MR, Ellison D, Stalteri M, Granowski A, Granowska M, et al. Imaging prostate cancer with technetium-99m-7E11-05.3 (CYT-351). J Nuel Med 1997; 38: 675–82.
  • Sodee DB, Conant R, Chalfant M, Miron S, Klein E, Bahnson R, et al. Preliminary imaging results using In-111-labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer. Clin Nuel Med 1996; 21: 759–67.
  • Israeli RS, Grob M, Fair WR. Prostate-specific antigen and other prostatic markers on the horizon. Urol Clin North Am 1997; 24: 439–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.